Dapagliflozin reduces the white coat effect on systolic blood pressure of patients with type 2 diabetes: a <i>post-hoc</i> analysis from the ADDENDA-BHS 2 trial
Authors
Wilson Nadruz (ORCID: https://orcid.org/0000-0002-0003-5102)
Dapagliflozin reduces the white coat effect on systolic blood pressure of patients with type 2 diabetes: a post-hoc analysis from the ADDENDA-BHS 2 trial
Wilson Nadruz, Íkaro Breder, Sheila T. Kimura-Medorima, Pamela Cavalcante et al.
Citations
1 citations
Journal
Current Medical Research and Opinion
Topics
Blood Pressure and Hypertension Studies
Field-Weighted Citation Impact (FWCI)
0.40
article
Dapagliflozin reduces the white coat effect on systolic blood pressure of patients with type 2 diabetes: a post-hoc analysis from the ADDENDA-BHS 2 trial
Wilson Nadruz, Íkaro Breder, Sheila T. Kimura-Medorima, Pamela Cavalcante, Andrei C. Spósito, Joaquim Barreto
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Current Medical Research and OpinionVol. 41(1)
Institutions
Universidade Estadual de Campinas (UNICAMP) (BR), Hospital de Clínicas da Unicamp (BR), Institute for Atherosclerosis Research (RU)